Stock Price
9.16
Daily Change
-0.38 -3.98%
Monthly
-0.33%
Yearly
31.04%
Q1 Forecast
9.00

Grifols reported EUR2.18B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
aTyr Pharma USD 190K 2.03M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.18B 37.55M Sep/2025